Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05169762
Other study ID # BICTX03
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2022
Est. completion date September 1, 2035

Study information

Verified date November 2022
Source Odense University Hospital
Contact Dorte Glintborg
Phone +4565411807
Email dorte.glintborg@rsyd.dk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.


Description:

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes: Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 1, 2035
Est. primary completion date September 1, 2035
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - assigned male at birth and eligeble for gender affirming feminizing treatment Exclusion Criteria: none -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
standard treatment
starndard treatment for transgender women

Locations

Country Name City State
Denmark OdenseUH Odense

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary coronary plaque formation mm3 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06093724 - Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV) N/A
Recruiting NCT04977765 - Cardiometabolic Health in Transgender Males
Recruiting NCT06074796 - The Determinants of Fertility Preservation in TRANSgender Patients.
Completed NCT04454970 - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Terminated NCT04551144 - Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Completed NCT04545450 - Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen Phase 3
Recruiting NCT05663892 - Drug-Drug Interaction Study in Trans Women Living With HIV Phase 4
Completed NCT05666102 - Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions N/A
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Not yet recruiting NCT06434805 - An Education Initiative to Reduce Stigma Towards Sex Workers and Sexual Minorities Among Nursing Students N/A
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Not yet recruiting NCT04154358 - Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men N/A
Recruiting NCT04254354 - Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Completed NCT04969003 - Reducing Transphobia Among Adolescents Through a Brief Video Intervention N/A
Completed NCT06149065 - Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
Not yet recruiting NCT06450405 - Androgen Effects on the Reproductive Neuroendocrine Axis
Not yet recruiting NCT06443164 - Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery N/A
Terminated NCT04275310 - Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women N/A
Not yet recruiting NCT05415930 - Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.